Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,049 | 43,269 | 66,196 | 40,181 | 65,466 |
| Marketable Securities | 24,688 | 40,157 | 21,175 | 55,103 | 17,381 |
| Receivables | 17,377 | 9,927 | 14,033 | 7,822 | 8,299 |
| Other current assets | 0 | 41,999 | 0 | 0 | 0 |
| TOTAL | $86,938 | $137,013 | $103,427 | $104,280 | $92,834 |
| Non-Current Assets | |||||
| PPE Net | 736 | 642 | 689 | 744 | 794 |
| Investments And Advances | 0 | 0 | 0 | 0 | 20,000 |
| Intangibles | 73,928 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 10,725 | 1,327 | 1,402 | 1,571 | 1,712 |
| TOTAL | $85,389 | $1,969 | $2,091 | $2,315 | $22,506 |
| Total Assets | $172,327 | $138,982 | $105,518 | $106,595 | $115,340 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 37,700 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 28,403 | 13,080 | 10,510 | 10,098 | 6,169 |
| Other current liabilities | 7,074 | 8,201 | 7,286 | 5,048 | 5,374 |
| TOTAL | $73,720 | $21,714 | $18,252 | $15,616 | $12,023 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,066 | 43,874 | 12,709 | 12,914 | 12,800 |
| Other Non-Current Liabilities | 31,677 | 5,924 | 6,058 | 6,661 | 15,397 |
| TOTAL | $36,743 | $49,798 | $18,767 | $19,575 | $28,197 |
| Total Liabilities | $110,463 | $71,512 | $37,019 | $35,191 | $40,220 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,426 | 36,218 | 33,933 | 33,882 | 34,540 |
| Common Shares | 4 | 3 | 3 | 3 | 3 |
| Retained earnings | -399,778 | -339,468 | -325,423 | -320,339 | -353,729 |
| Other shareholders' equity | -26 | -203 | -208 | -46 | 577 |
| TOTAL | $61,864 | $67,470 | $68,499 | $71,404 | $75,120 |
| Total Liabilities And Equity | $172,327 | $138,982 | $105,518 | $106,595 | $115,340 |